Impact of upper digestive symptoms in patients with irritable bowel syndrome

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 12, 2006, Pages 1271-1277

  Balboa, Agustín ^a   Mearin, Fermín ^a   Badía, Xavier ^b   Benavent, Jaume ^c   Caballero, Antonio María ^f   Domínguez Muñoz, José Enrique ^g   Garrigues, Vicente ^h   Piqué, José María ^d   Roset, Montse ^b   Cucala, Mercedes ^e   Figueras, Montse ^e  

^a CENTRO MÉDICO TEKNON   (Spain)

^b Health Outcomes Research Europe   (Spain)

^c Primary Healthcare Center 'Clinic'   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e Novartis Farmacéutica S A   (Spain)

^f UNIVERSITY OF GRANADA   (Spain)

^g Instituto de Salud Carlos III   (Spain)

^h HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Dyspepsia; Functional dyspepsia; Gastroesophageal reflux disease; Health related quality of life; Heartburn; Irritable bowel syndrome; Psychological status

Indexed keywords

ADULT; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUESTIONNAIRE; SPAIN; UPPER GASTROINTESTINAL TRACT; WELLBEING;

EID: 33750942163     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000243870.41207.2f     Document Type: Article

References (36)

1. Bixquert M. Epidemiología de la dispepsia funcional: importancia sanitaria, social y económica (The epidemiology of functional dyspepsia: health and socioeconomic importance). In: Mearin F, editor. Dispepsia funcional: tan desconocida como frecuente (Functional dyspepsia: as unknown as frequent). Barcelona, SA: Ediciones Doyma; 1997. pp. 11-18.
2. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000; 46:78-82.
3. Knill-Jones RP. Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol 1991; 182 (Suppl):17-24.
4. Fullerton S. Functional digestive disorders in the year 2000. Economic impact. Eur J Surg 1998; 582 (Suppl):62-64.
5. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000; 95:67-71.
6. Thompson WG, Longstreth G, Drossman DA, Heaton K, Irvine EJ, Muller-Lissner S. Functional bowel disorders and functional abdominal pain. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, editors. Rome II. The functional gastrointestinal disorders. 2nd ed. McLean, Virginia: Degnon Associates; 2000. pp. 351-432.
7. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, editors. Rome II. The functional gastrointestinal disorders. 2nd ed. McLean, Virginia: Degnon Associates; 2000. pp. 299-350.
8. Balboa A, Mearin F. Características epidemiológicas e importancia socioeconómica del síndrome del intestino irritable (Epidemiological characteristics and socioeconomic importance of irritable bowel syndrome) [in Spanish]. Rev Esp Enf Dig 2000; 92:806-812.
9. Mearin F, Badía X, Balboa A, Baró E, Caldwell E, Cucala M, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001; 36:1155-1161.
10. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109:671-680.
11. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136:165-177.
12. Caballero-Plasencia AM, Sofos-Kontoyannis S, Valenzuela-Barranco M, Martín-Ruíz JL, Casado-Caballero FJ, Guilarte-López- Mañas J. Irritable bowel syndrome in patients with dyspepsia: a community-based study in southern Europe. Eur J Gastroenterol Hepatol 1999; 11:517-522.
13. Kennedy TM, Jones RH, Hungin APS, O'Flanagan H, Kelly P. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 1998; 43:770-774.
14. Pimentel M, Rossi F, Chow EJ, Ofman J, Fullerton S, Hassard P, et al. Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. J Clin Gastroenterol 2002; 34:221-224.
15. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38:1569-1580.
16. Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998; 42:690-695.
17. Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005; 100:1174-1184.
18. Patrick DL, Drossman DA, Frederik IO, Dicesare J, Puder K. Quality of life in persons with irritable bowel syndrome. Development and validation of a new measure. Dig Dis Sci 1998; 43:400-411.
19. Badia X, Herdman M, Mearin F, Perez I. Adaptación al español del cuestionario IBS-QOL para la medición de la calidad de vida en pacientes con síndrome del intestino irritable (Spanish adaptation of IBS-QOL questionnaire for measurement of quality of life in irritable bowel syndrome patients) [in Spanish]. Rev Esp Enf Dig 2000; 92:637-643.
20. Badia X, Roset M, Monserrat S, Herdman M, Segura A. La versión española del EuroQol: descripción y aplicaciones (The Spanish version of Euro-QoL: a description and its applications. European Quality of Life scale) [in Spanish]. Med Clin 1999; 112 (Suppl 1):79-85.
21. Badia X, Gutierrez F, Wiklund I, Alonso J. Validity and reliability of the Spanish version of the Psychological General Well-Being Index. Qual Life Res 1996; 5:101-108.
22. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000; 95:3176-3183.
23. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol 1997; 92:954-959.
24. Caballero-Plasencia AM, Valenzuela-Barranco M, Herrerias-Gutierrez JM, Esteban-Carretero JM. Altered gastric emptying in patients with irritable bowel syndrome. Eur J Nucl Med 1999; 26:404-409.
25. Portincasa P, Moschetta A, Baldassarre G, Altomare DF, Palasciano G. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol 2003; 9:2293-2299.
26. Stanghellini V, Tosetti C, Barbara G, De Giorgio R, Cogliandro L, Cogliandro R, et al. Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol 2002; 97:2738-2743.
27. Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003; 98:2454-2459.
28. Mearin F, Balboa A, Badía X, Baró E, Caldwell E, Cucala M, et al. Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003; 15:165-172.
29. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001; 96:2905-2914.
30. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995; 40:584-589.
31. Gutiérrez A, Rodrigo L, Riestra S, Fernández E, Cadahia V, Tojo R, et al. Quality of life in patients with functional dyspepsia: a prospective 1-year follow-up study in Spanish patients. Eur J Gastroenterol Hepatol 2003; 15:1175-1181.
32. Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K, et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol 1999; 94:1782-1789.
33. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease: an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003; 18:767-776.
34. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999; 45 (Suppl II):25-30.
35. Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K, et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol 1999; 94:1782-1789.
36. Gutiérrez A, Rodrigo L, Riestra S, Fernández E, Cadahia V, Tojo R, et al. Quality of life in patients with functional dyspepsia: a prospective 1-year follow-up study in Spanish patients. Eur J Gastroenterol Hepatol 2003; 15:1175-1181.